Samsung Biologics’ Plant 4 in Incheon / Courtesy of Samsung Biologics
By Nam Hyun-woo
Samsung Biologics introduced on Tuesday that it acquired certification from a worldwide security certification firm for its efforts to cut back landfill waste, marking the primary such occasion amongst Korean bio and pharmaceutical companies.
World security agency Underwriters Laboratories granted a Zero Waste to Landfill certification to Samsung Biologics, which is predicated in Songdo, Incheon, for its 85.4 % landfill waste diversion price recorded in 2023, the corporate mentioned.
Zero Waste to Landfill is a waste diversion validation program that evaluates the landfill waste diversion charges of organizations and grants completely different designations — platinum for one hundred pc, gold for 95 to 99 %, silver for 90 to 94 % and licensed for these attaining over 80 %.
Samsung Biologics mentioned the certification is important as a result of waste recycling is comparatively troublesome for biopharmaceutical companies, which should incinerate medical waste whereas utilizing numerous supplies in small portions.
Samsung Biologics’ Inexperienced Middle / Courtesy of Samsung Biologics
Final 12 months, Samsung Biologics established a 1,815 square-meter recycling unit known as Inexperienced Middle to course of basic and designated waste individually. This 12 months, the corporate improved its waste recycling price by individually amassing artificial resin waste and natural solvent waste, and has been recycling the previous which initially was incinerated.
“Samsung Biologics grew to become the primary firm in Korea to win the certification due to its top-tier waste administration system,” Samsung Biologics Vice President Park Se-gang mentioned.
“We’ll proceed to strengthen our waste administration and purchase greater designations.”
Samsung Biologics additionally confirmed enhancements in its earnings for the third quarter of this 12 months. Earlier this month, the corporate posted 1.19 trillion received ($859 million) in income and 338.6 billion received in working revenue. The gross sales grew 15 % year-on-year and the working revenue additionally inched up by 6 % year-on-year. It was the primary time that the corporate logged quarterly gross sales surpassing 1 trillion received.
